160 related articles for article (PubMed ID: 15596760)
1. Cerebral vasospasm from sumatriptan.
Dash S; Bogdanova O; Xavier A; Farkas J; Pullicino P
Neurology; 2004 Dec; 63(11):2128. PubMed ID: 15596760
[No Abstract] [Full Text] [Related]
2. Tolerability of sumatriptan: clinical trials and postmarketing experience.
Allen C; Dayno J
Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
[No Abstract] [Full Text] [Related]
3. Triptans and migraine.
Bateman DN
Lancet; 2000 Mar; 355(9207):860-1. PubMed ID: 10752697
[No Abstract] [Full Text] [Related]
4. Looking forward: the expanding utility of sumatriptan and naratriptan.
Cady R
Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
[No Abstract] [Full Text] [Related]
5. The hazards of medication refills by telephone.
Solomon S
Headache; 2002 Sep; 42(8):835. PubMed ID: 12390654
[No Abstract] [Full Text] [Related]
6. Ischemic colitis and sumatriptan use.
Knudsen JF; Friedman B; Chen M; Goldwasser JE
Arch Intern Med; 1998 Sep; 158(17):1946-8. PubMed ID: 9759693
[TBL] [Abstract][Full Text] [Related]
7. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
Goldstein D
Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
[No Abstract] [Full Text] [Related]
8. Building on the sumatriptan experience: the development of naratriptan.
Connor HE
Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
[No Abstract] [Full Text] [Related]
9. A case of sumatriptan-induced intestinal ischemia.
Repaka A; Wenger J; Sitaraman SV
J Gastroenterol; 2006 Feb; 41(2):177-8. PubMed ID: 16568377
[No Abstract] [Full Text] [Related]
10. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
Mathew NT; Kailasam J; Gentry P; Chernyshev O
Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
[TBL] [Abstract][Full Text] [Related]
11. How to assess patient preference of migraine treatments.
Dahlöf C
Cephalalgia; 1999 Jul; 19 Suppl 24():2-5; discussion 5-6. PubMed ID: 10526675
[No Abstract] [Full Text] [Related]
12. Vasospasm-induced myocardial infarction with sumatriptan.
Mueller L; Gallagher RM; Ciervo CA
Headache; 1996 May; 36(5):329-31. PubMed ID: 8682677
[TBL] [Abstract][Full Text] [Related]
13. [Choice of triptan in migraine].
Salvesen R
Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3410-1. PubMed ID: 11826788
[No Abstract] [Full Text] [Related]
14. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
Welch KM
Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
[No Abstract] [Full Text] [Related]
15. Sumatriptan-induced chest symptoms in Japanese.
Hirata K
Intern Med; 2002 Aug; 41(8):599-600. PubMed ID: 12211521
[No Abstract] [Full Text] [Related]
16. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
Géraud G; Valette C
Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
[TBL] [Abstract][Full Text] [Related]
17. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
18. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW
Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167
[TBL] [Abstract][Full Text] [Related]
19. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.
Visser WH; Jaspers NM; de Vriend RH; Ferrari MD
Cephalalgia; 1996 Dec; 16(8):554-9. PubMed ID: 8980858
[TBL] [Abstract][Full Text] [Related]
20. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
Mathew NT
Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
